
First malaria drug for newborns and young infants expected to be approved in Africa within weeks
CNN — The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, drugmaker Novartis said Tuesday. The drug, known as Coartem Baby or Riamet Baby in some countries, has been approved by …